biguanides has been researched along with Dyslipidemia in 2 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jellinger, PS | 1 |
| Rabasseda, X | 1 |
1 review available for biguanides and Dyslipidemia
| Article | Year |
|---|---|
Metabolic consequences of hyperglycemia and insulin resistance.
Topics: Biguanides; Cannabinoid Receptor Modulators; Cardiovascular Diseases; Dyslipidemias; Fatty Acids, No | 2007 |
1 other study available for biguanides and Dyslipidemia
| Article | Year |
|---|---|
From insulin to incretins: a report from the 67th scientific sessions of the American Diabetes Association.
Topics: Biguanides; Diabetes Complications; Diabetes Mellitus; Diet; Dietary Supplements; Dipeptidyl-Peptida | 2007 |